SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
AEterna Zentaris: FDA Grants IND to Investigator at University of Miami School of Medicine for Phase 2 Trial with AEZS-108 in Triple-Negative Breast Cancer